Fortress Biotech, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Accounts Payable and Accrued Expenses (Tables)

Accounts Payable and Accrued Expenses (Tables)

12 Months Ended

Dec. 31, 2022

Accounts Payable and Accrued Expenses

Schedule of accounts payable and accrued expenses

Accounts payable and accrued expenses consisted of the following:


		December 31,				December 31,
($ in thousands)		2022			2021

Accounts payable		$	57,244		$	47,429
Accrued expenses:
Professional fees			1,693			1,835
Salaries, bonus and related benefits			9,772			8,809
Research and development			7,390			7,932
Research and development - license maintenance fees			632			4,640
Research and development - milestones			4,600			850
Accrued royalties payable			2,627			3,833
Accrued coupon and rebates			7,604			10,603
Return reserve			3,689			3,240
Accrued interest			342			—
Other			1,853			1,489
Total accounts payable and accrued expenses		$	97,446		$	90,660